Skip to content

Recent SARS-CoV-2 infections and increased antibody responses to viral antigens are associated with greater autoantibody reactivity.

Jul 2026 · Immunology Letters · Vol 282, pp. 107212 · 0 citations · 59 references
Medicine

TL;DR

SARS-CoV-2 infection and the intensity of IgG responses to the spike protein were associated with increased autoantibody reactivity, a potential indicator of latent autoimmunity.

Abstract

Background

SARS-CoV-2-induced latent autoimmunity may play a role in long-COVID symptoms. This study explored associations between serum immunoglobulin G (IgG) responses to 18 self-antigens and antibody responses to SARS-CoV-2 and common chronic infections: Epstein-Barr virus (EBV), cytomegalovirus (CMV), Helicobacter pylori, and Toxoplasma gondii.

Methods

This cross-sectional study used 179 SARS-CoV-2 convalescent serum samples acquired from biobanks and 123 pre-pandemic serum samples. IgG responses to SARS-CoV-2 spike, receptor binding domain, spike subunit 2, and nucleocapsid antigens were measured using an in-house Luminex multiplexed suspension fluorescence immunoassay. IgG responses to four chronic infections were quantified using commercial ELISA kits. Autoantibody responses to 18 self-antigens were simultaneously measured using a commercially available multiplexed Luminex assay; combined autoantibody reactivity was defined as the geometric mean of the 18 individual autoantibody responses.

Results

Combined autoantibody reactivity and responses to several individual self-antigens were significantly higher in SARS-CoV-2 convalescent, seropositive individuals than in seronegative pre-pandemic controls. Associations between CMV, EBV, H. pylori, and T. gondii seropositivity and combined autoantibody reactivity were not statistically significant. Stronger antibody responses to antigens of the SARS-CoV-2 spike protein (S, S2, and RBD) in convalescent individuals were significantly associated with greater combined autoantibody reactivity and increased responses to multiple individual self-antigens. Conversely, antibody responses to antigens of CMV, EBV, H. pylori, and T. gondii in corresponding subsets of seropositive individuals were not associated with combined autoantibody reactivity.

Conclusion

SARS-CoV-2 infection and the intensity of IgG responses to the spike protein were associated with increased autoantibody reactivity, a potential indicator of latent autoimmunity.

View source

Similar papers

Jul 2026

Anti-SARS-CoV-2 receptor-binding domain IgG titers and associated factors after heterologous mRNA booster vaccination in individuals primed with the inactivated vaccine.

Lower humoral immune responses with increasing time after heterologous mRNA booster vaccination in individuals primed with CoronaVac and may inform future booster strategies are suggested.

H. Harapan, A. P. Ayulinda, Qatrunnada Kamil et al. · 0 citations
Open access Aug 2026

Early HHV-6 IgG and IgA responses during acute SARS-CoV-2 infection in relation to long COVID: a multicohort observational study

Early herpesvirus-directed antibody responses following SARS-CoV-2 infection exhibit distinct virus- and isotype-specific patterns associated with long COVID, suggesting that heterogeneity in long COVID may be linked to differential herpesvirus-directed humoural immune responses that emerge early after infection.

Ananya Choudhury, M. Burry, W. Kwon et al. · 0 citations
Open access Jul 2026

Salivary polyreactive and SARS-CoV-2-specific antibody responses following SARS-CoV-2 infection and vaccination in healthcare workers.

SARS-CoV-2 infection, but not vaccination, induces distinct changes in the salivary IgA compartment, including polyreactive antibodies, which may reflect repeated mucosal immune stimulation and is associated with greater symptom burden.

Mischa H. Koenen, Juana Claus, Myrthe E Reiche et al. · 0 citations
Open access Sep 2026

Beyond seropositivity: SARS-CoV-2 IgG responses in high-risk COVID-19 patients.

Findings highlight variant-specific limitations of anti-Spike IgG as a universal marker of protection and support the need for integrated serological and virological assessment to guide antiviral and monoclonal antibody strategies in vulnerable populations.

Matteo Domenico Marsiglia, Roberta Rovito, A. Amendola et al. · 0 citations
Review Open access Sep 2026

Measurement of binding antibodies to SARS-CoV-2 variants elicited by natural infection and COVID-19 vaccines in a sub-Saharan African population

These findings provide rare data on variant-specific vaccine-elicited antibody binding responses in West and Central African populations with distinct demographic, epidemiologic, and immunologic background.

E. Lusamaki, Ana M. Ortega-Villa, Daouda Camara et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.